John Higgins
Chairman bei OMNIAB, INC.
Vermögen: 47 Mio $ am 31.03.2024
Profil
John L.
Higgins is currently the Chief Executive Officer at Metabasis Therapeutics, Inc. He is also the Chief Executive Officer at CyDex Pharmaceuticals, Inc. and the Chairman at OmniAb Operations, Inc., OmniAb, Inc., and the Academy of Whole Learning.
Additionally, he serves as an Independent Director at Bio-Techne Corp.
and as a Director at Pelican Inc. In the past, Mr. Higgins worked as a Director at BioCryst Pharmaceuticals, Inc. from 1994 to 2013.
He was also a Director at Ligand Pharmaceuticals, Inc. from 2007 to 2022.
He served as the CFO & EVP-Administration & Corporate Development at Connetics Corp.
from 1997 to 2006.
Furthermore, he was a Member of the Healthcare Banking Team at Dillon, Read & Co., Inc. Mr. Higgins obtained his undergraduate degree from Colgate University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2023 | 417 695 ( 2,36% ) | 31 Mio $ | 31.03.2024 | |
OMNIAB, INC.
2,19% | 30.01.2024 | 2 559 576 ( 2,19% ) | 14 Mio $ | 31.03.2024 |
BIO-TECHNE CORPORATION
0,02% | 26.10.2023 | 36 608 ( 0,02% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von John Higgins
| Unternehmen | Position | Beginn |
|---|---|---|
| BIO-TECHNE CORPORATION | Director/Board Member | 19.05.2009 |
| PFENEX INC. | Director/Board Member | 01.10.2020 |
| OMNIAB, INC. | Chairman | 01.11.2022 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Chief Executive Officer | 01.01.2010 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Chairman | - |
Academy of Whole Learning
 Academy of Whole Learning Miscellaneous Commercial ServicesCommercial Services Academy of Whole Learning provides a comprehensive educational experience for children with autism spectrum disorder and learning difficulties. The private company is based in Minnetonka, MN. | Chairman | - |
CyDex Pharmaceuticals, Inc.
 CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von John Higgins
| Unternehmen | Position | Ende |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Chief Executive Officer | 05.12.2022 |
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | - |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Ausbildung von John Higgins
| Colgate University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| BIO-TECHNE CORPORATION | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| OMNIAB, INC. | Commercial Services |
| Private Unternehmen | 9 |
|---|---|
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Health Technology |
| Dillon, Read & Co., Inc. | Finance |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Blue Zones LLC
 Blue Zones LLC Medical/Nursing ServicesHealth Services Blue Zones LLC provides healthcare services. The company was founded by Dan Buettner and is headquartered in Minneapolis, MN. | Health Services |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
Academy of Whole Learning
Academy of Whole Learning Miscellaneous Commercial ServicesCommercial Services Academy of Whole Learning provides a comprehensive educational experience for children with autism spectrum disorder and learning difficulties. The private company is based in Minnetonka, MN. | Commercial Services |
